Because UCSF is home to the Helen Diller Family Comprehensive Cancer Center (HDFCCC), designated and supported by the National Cancer Institutute (NCI), all protocols designed to conduct research on subjects diagnosed with, or at risk for, cancer are subject to additional review and monitoring processes not required of non-cancer protocols. Therefore, in addtion to requiring review by the Committee on Human Research (CHR), your cancer-related protocols are subject to:
Such protocols may also be eligible to receive centralized support from the Investigational Trials Resource.
Other Clinical Research Resources
* Can include studies written by an investigator at another institution.